Updated Jul 16, 2026
Lee Frank D. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $255K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | BHC | Bausch Health Companies Inc. | A — Grant or award | 45.9K | $0.00 | |
| 2026-05-20 | BHC | Bausch Health Companies Inc. | S — Open-market sale | 24.5K | $5.43 | $133K |
| 2026-02-13 | PCRX | Pacira BioSciences, Inc. | A — Grant or award | 261.8K | $0.00 | |
| 2026-02-03 | PCRX | Pacira BioSciences, Inc. | F — Tax withholding / forfeiture | 41.5K | $20.54 | $852K |
| 2025-08-21 | BHC | Bausch Health Companies Inc. | S — Open-market sale | 15.9K | $7.66 | $122K |
Lee Frank D. is a corporate insider — currently tracked as Director of Bausch Health Companies Inc. (BHC). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($255K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lee Frank D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.